SecSonar.com

ADC Therapeutics S.A. (ADCT)

ADC Therapeutics S.A. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

ADC Therapeutics S.A. (ADCT) is a Biotechnology company based in CH with a market capitalization of $433.1M. Revenue grew 14.8% year-over-year and free cash flow was negative at -$141.4M. This page tracks ADCT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CH · 263 employees · IPO May 18, 2020

Valuation

Valuation & price

$3.42 · as of May 26, 2026 · -30.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$4.80$2.91$1.02Jul 25Dec 25Jul 26Jul 7, 25$2.70Jul 9, 25$3.15Jul 11, 25$3.15Jul 15, 25$3.25Jul 17, 25$3.11Jul 21, 25$3.14Jul 23, 25$3.20Jul 25, 25$3.28Jul 29, 25$2.89Jul 31, 25$2.77Aug 4, 25$2.73Aug 6, 25$2.64Aug 11, 25$2.68Aug 13, 25$3.09Aug 15, 25$3.13Aug 19, 25$3.11Aug 21, 25$3.10Aug 25, 25$3.09Aug 27, 25$3.22Aug 29, 25$3.07Sep 3, 25$3.29Sep 5, 25$3.54Sep 9, 25$3.32Sep 11, 25$3.33Sep 16, 25$3.31Sep 18, 25$3.39Sep 22, 25$3.48Sep 24, 25$3.56Sep 26, 25$3.65Sep 30, 25$4.00Oct 2, 25$3.98Oct 6, 25$4.43Oct 8, 25$4.54Oct 10, 25$4.42Oct 14, 25$4.11Oct 16, 25$4.13Oct 21, 25$4.13Oct 23, 25$4.07Oct 27, 25$4.29Oct 29, 25$4.61Oct 31, 25$4.46Nov 4, 25$4.03Nov 6, 25$4.16Nov 10, 25$4.21Nov 12, 25$4.05Nov 14, 25$3.96Nov 18, 25$4.00Nov 20, 25$3.99Nov 25, 25$4.39Nov 28, 25$4.30Dec 2, 25$4.60Dec 4, 25$3.54Dec 8, 25$3.22Dec 10, 25$4.01Dec 12, 25$4.23Dec 16, 25$3.97Dec 18, 25$3.90Dec 22, 25$3.70Dec 24, 25$3.53Dec 29, 25$3.50Jan 2, 26$3.52Jan 6, 26$3.54Jan 8, 26$3.57Jan 12, 26$3.82Jan 14, 26$3.71Jan 16, 26$3.62Jan 21, 26$3.57Jan 23, 26$3.61Jan 27, 26$3.59Jan 29, 26$3.76Feb 2, 26$3.90Feb 4, 26$4.09Feb 9, 26$3.99Feb 11, 26$3.92Feb 13, 26$3.99Feb 18, 26$4.13Feb 20, 26$4.10Feb 24, 26$4.39Feb 26, 26$4.13Mar 2, 26$4.18Mar 4, 26$4.24Mar 6, 26$4.11Mar 10, 26$4.80Mar 12, 26$4.35Mar 17, 26$4.11Mar 19, 26$4.04Mar 23, 26$4.05Mar 25, 26$3.97Mar 27, 26$3.70Mar 31, 26$3.75Apr 2, 26$3.78Apr 7, 26$3.72Apr 9, 26$3.76Apr 13, 26$3.81Apr 15, 26$4.37Apr 17, 26$4.28Apr 22, 26$4.09Apr 24, 26$3.94Apr 28, 26$3.77Apr 30, 26$3.78May 4, 26$3.68May 6, 26$3.86May 8, 26$3.50May 12, 26$3.43May 14, 26$3.36May 18, 26$3.17May 20, 26$3.24May 22, 26$3.39May 28, 26$3.45Jun 1, 26$3.40Jun 3, 26$3.08Jun 5, 26$1.03Jun 9, 26$1.10Jun 11, 26$1.06Jun 15, 26$1.05Jun 17, 26$1.11Jun 22, 26$1.09Jun 24, 26$1.07Jun 26, 26$1.02Jul 2, 26$1.19
$0.9852-week range$4.88
Loading valuation history…

Fundamentals

Key fundamentals

$433.1M

Market cap

14.8%

Revenue growth (YoY)

90.6%

Gross margin

-$141.4M

Free cash flow (USD)

$177.7M

Net debt

30.8%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$1.8MFY 2018$1.1MFY 2019$2.3MFY 2020$0.00FY 2021$33.9MFY 2022$209.9MFY 2023$69.6MFY 2024$70.8MFY 2025$81.4M
$1.8M$81.4M

Free cash flow by year

2017 → 2025

FY 2017$-78.1MFY 2018$-123.8MFY 2019$-123.7MFY 2020$-171.5MFY 2021$-239.8MFY 2022$-139.0MFY 2023$-121.9MFY 2024$-124.7MFY 2025$-141.4M
-$78.1M-$141.4M

Gross margin by year

2021 → 2025

FY 202195.9%FY 202298.4%FY 202396.4%FY 202491.6%FY 202590.6%
95.9%90.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 4, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventRetention Awards GrantedJul 2, 2026Filing
  • 8-K eventWorkforce ReductionJun 24, 2026Filing
  • 8-K eventClinical Trial ResultsJun 3, 2026Filing
  • 8-K eventArticles of AssociationJun 2, 2026Filing
  • 8-K eventEarnings ReleaseMay 4, 2026Filing
  • Quarterly report10-Q FiledMay 4, 2026Filing

Questions

Frequently asked questions

What is ADC Therapeutics S.A.'s market cap?

ADC Therapeutics S.A. (ADCT) has a market capitalization of $433.1M.

What is ADCT's P/E ratio?

A meaningful P/E ratio is not available for ADCT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying ADCT stock?

SEC Form 4 filings show no open-market insider buys at ADC Therapeutics S.A. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

PRTC

PureTech Health plc

$439.4M

NGNE

Neurogene Inc.

$441.4M

ASMB

Assembly Biosciences, Inc.

$441.9M

DBVT

DBV Technologies S.A.

$454.8M

LYEL

Lyell Immunopharma, Inc.

$406.2M

XFOR

X4 Pharmaceuticals, Inc.

$402.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.